Paul B. Bolno, M.D., MBA, is the President and Chief Executive Officer at WAVE Life Sciences Ltd., a biotechnology company focused on developing innovative treatments for serious diseases. Dr. Bolno has a distinguished career in the life sciences industry, bringing a wealth of experience and expertise to his leadership role at WAVE. He holds an M.D. from the University of Pennsylvania School of Medicine and an MBA from The Wharton School of the University of Pennsylvania, showcasing his strong foundation in both medicine and business. Before joining WAVE Life Sciences, Dr. Bolno held several key positions in the biotechnology sector. He served as the Chief Medical Officer and Senior Vice President of Clinical Development at Voyager Therapeutics, where he played a crucial role in advancing the company's gene therapy programs. Prior to that, he was the Senior Vice President of Clinical Development at Biogen Idec, where he led the development of multiple sclerosis therapies that have significantly impacted patient care. Dr. Bolno's extensive experience in clinical development and his strategic vision have been instrumental in guiding WAVE Life Sciences' efforts to bring transformative therapies to market. As President and CEO of WAVE Life Sciences, Dr. Bolno is responsible for overseeing the company's overall strategy and operations. Under his leadership, WAVE has made significant progress in its RNA-targeted therapeutic platforms, focusing on diseases with high unmet medical needs. Dr. Bolno's commitment to scientific innovation and patient-centric approaches has positioned WAVE Life Sciences as a leader in the development of precision genetic medicines. His leadership continues to drive the company forward, fostering collaborations and advancing clinical programs that aim to improve the lives of patients worldwide.